Trial intelligence / Profile preview

Duloxetine fMRI Response in Major Depression

NCT00532480Phase 4Completed

Sponsor
Indiana University School of Medicine
Start
Sep 2007
Primary completion
Apr 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of duloxetine in major depressive disorder (MDD), sponsored by Indiana University School of Medicine. Started Sep 2007; status: completed.

02

Drugs

duloxetine
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT00532480.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00532480.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call